Historical Stock Price
| Home |
| Free Dividend Report |
| Stock Splits Calendar |
| ABIO Historical Stock Prices |
| Preferred Stock Newsletter |
| ABIO Options Chain |
| Stock Message Boards |
ARCA biopharma (ABIO) has the following price history information. Looking back at ABIO historical stock prices for the last five trading days, on March 21, 2023, ABIO opened at $2.05, traded as high as $2.14 and as low as $2.01, and closed at $2.11. Trading volume was a total of 82.30K shares. On March 22, 2023, ABIO opened at $2.10, traded as high as $2.10 and as low as $2.05, and closed at $2.05. Trading volume was a total of 15.40K shares. On March 23, 2023, ABIO opened at $2.05, traded as high as $2.08 and as low as $2.01, and closed at $2.03. Trading volume was a total of 25.70K shares. On March 24, 2023, ABIO opened at $2.00, traded as high as $2.08 and as low as $2.00, and closed at $2.08. Trading volume was a total of 33.60K shares. On March 27, 2023, ABIO opened at $2.06, traded as high as $2.10 and as low as $2.02, and closed at $2.07. Trading volume was a total of 11.50K shares.
ABIO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into ARCA biopharma shares, starting with a $10,000 purchase of ABIO, and working forward through the historical stock price information to today.
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 04/01/2013 | |
| End date: | 03/27/2023 | |
| Start price/share: | $279.72 | |
| End price/share: | $2.07 | |
| Dividends collected/share: | $0.00 | |
| Total return: | -99.26% | |
| Average Annual Total Return: | -38.80% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $74.01 | |
| Years: | 9.99 | |
 | |||||
| ABIO Historical Price Range | |||||
| Date | Open | High | Low | Close | Volume |
| 03/21/2023 | $2.05 | $2.14 | $2.01 | $2.11 | 82.30K |
| 03/22/2023 | $2.10 | $2.10 | $2.05 | $2.05 | 15.40K |
| 03/23/2023 | $2.05 | $2.08 | $2.01 | $2.03 | 25.70K |
| 03/24/2023 | $2.00 | $2.08 | $2.00 | $2.08 | 33.60K |
| 03/27/2023 | $2.06 | $2.10 | $2.02 | $2.07 | 11.50K |
|
| About ARCA biopharma |
| ARCA biopharma is a clinical-stage biopharmaceutical company. Co.'s primary product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2 (AB201)) as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro™ (bucindolol hydrochloride) for the treatment of atrial fibrillation in patients with chronic heart failure. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy. |
| ABIO Historical Closing Prices | |
| Date | Close |
| 03/21/2023 | $2.11 |
| 03/22/2023 | $2.05 |
| 03/23/2023 | $2.03 |
| 03/24/2023 | $2.08 |
| 03/27/2023 | $2.07 |
| Healthcare Historical Prices |
| ABIO is categorized under the Healthcare sector; below are some other companies in the same sector:
ABMD Historical Stock Prices Also explore: ABIO shares outstanding history
|
Free ABIO Email Alerts:
